Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Rubello

Showing results (141-150 of 471) with videos related to

Pageof 48
Sort By:
European Journal of Endocrinology|June 29, 2002
Functional scintigraphy of the adrenal glandDomenico Rubello, Chuong Bui, Dario Casara, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2011
The sentinel node procedure in breast cancer: nuclear medicine as the starting pointElif Hindié, David Groheux, Isabelle Brenot-Rossi, et al.
Nuclear Medicine Communications|March 12, 2011
Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancerPaolo Castellucci, Chiara Fuccio, Maria Cristina Marzola, et al.
European Journal of Endocrinology|June 26, 2003
Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: optimization of preoperative and intraoperative proceduresDomenico Rubello, Andrea Piotto, Dario Casara, et al.
Nuclear Medicine Communications|April 1, 2014
What is the role of preoperative scintigraphic imaging and the intraoperative gamma probe in secondary hyperparathyroidism?David Fuster, Sergi Vidal-Sicart, José-Vicente Torregrosa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2012
Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?Valentina Ambrosini, Davide Campana, Cristina Nanni, et al.
Nuclear Medicine Communications|April 9, 2016
Role of myocardial perfusion scintigraphy in predicting global cardiovascular risk and differentiating between patients with moderate and high cardiovascular riskMarco Zuin, Lucia Rampin, Massimo Rinuncini, et al.
Nuclear Medicine Communications|July 27, 2013
The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option?Cristina Nanni, Riccardo Schiavina, Domenico Rubello, et al.
In Vivo (Athens, Greece)|February 6, 2010
Radioguided surgery and systemic radionuclide therapy of neuroendocrine tumoursMarina Hodolic, Jure Fettich, Maria Cristina Marzola, et al.
Clinical Nuclear Medicine|February 23, 2013
(18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective studyValentina Ambrosini, Maurizio Zompatori, Luca Fasano, et al.
Pageof 48

Showing results (141-150 of 471) with videos related to

Sort By:
Pageof 48
European Journal of Endocrinology|June 29, 2002
Functional scintigraphy of the adrenal glandDomenico Rubello, Chuong Bui, Dario Casara, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2011
The sentinel node procedure in breast cancer: nuclear medicine as the starting pointElif Hindié, David Groheux, Isabelle Brenot-Rossi, et al.
Nuclear Medicine Communications|March 12, 2011
Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancerPaolo Castellucci, Chiara Fuccio, Maria Cristina Marzola, et al.
European Journal of Endocrinology|June 26, 2003
Role of gamma probes in performing minimally invasive parathyroidectomy in patients with primary hyperparathyroidism: optimization of preoperative and intraoperative proceduresDomenico Rubello, Andrea Piotto, Dario Casara, et al.
Nuclear Medicine Communications|April 1, 2014
What is the role of preoperative scintigraphic imaging and the intraoperative gamma probe in secondary hyperparathyroidism?David Fuster, Sergi Vidal-Sicart, José-Vicente Torregrosa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2012
Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?Valentina Ambrosini, Davide Campana, Cristina Nanni, et al.
Nuclear Medicine Communications|April 9, 2016
Role of myocardial perfusion scintigraphy in predicting global cardiovascular risk and differentiating between patients with moderate and high cardiovascular riskMarco Zuin, Lucia Rampin, Massimo Rinuncini, et al.
Nuclear Medicine Communications|July 27, 2013
The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option?Cristina Nanni, Riccardo Schiavina, Domenico Rubello, et al.
In Vivo (Athens, Greece)|February 6, 2010
Radioguided surgery and systemic radionuclide therapy of neuroendocrine tumoursMarina Hodolic, Jure Fettich, Maria Cristina Marzola, et al.
Clinical Nuclear Medicine|February 23, 2013
(18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective studyValentina Ambrosini, Maurizio Zompatori, Luca Fasano, et al.
Pageof 48